These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3376801

  • 1. [Clinical effect of terodiline hydrochloride (TD-758) in patients with urinary disturbances].
    Nakano M, Tajima A, Aso Y, Suzuki K, Hata M, Tsukada T, Masuda H, Hirose J, Kitagawa M, Nakahara M.
    Hinyokika Kiyo; 1988 Jan; 34(1):196-200. PubMed ID: 3376801
    [Abstract] [Full Text] [Related]

  • 2. [Clinical effects of terodiline hydrochloride for urinary frequency and sense of residual urine].
    Fujiwara E, Nakano H, Nihira H, Kitano T, Ukai R, Masu C, Onishi Y, Kodama M, Hatachi K, Matsuki A.
    Hinyokika Kiyo; 1988 Apr; 34(4):733-8. PubMed ID: 3400553
    [Abstract] [Full Text] [Related]

  • 3. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
    Ogawa A, Shimazaki J, Mitsuya H, Miyazaki S, Kurita T.
    Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
    [Abstract] [Full Text] [Related]

  • 4. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
    Yoshihara H, Yasumoto R, Kishimoto T, Maekawa M, Horii A, Nishijima T, Sugimoto T, Kashiwara N, Tsujita M, Senjyu M.
    Hinyokika Kiyo; 1992 Aug; 38(8):967-72. PubMed ID: 1414748
    [Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of terodiline hydrochloride in patients with urinary frequency or incontinence].
    Yasuno H, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Kataoka N, Matsushita M, Inaba Y, Umezu K, Yamashita M.
    Hinyokika Kiyo; 1991 Apr; 37(4):431-9. PubMed ID: 1892003
    [Abstract] [Full Text] [Related]

  • 6. [Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder].
    Yoneyama T, Ogawa A, Fukui J, Wajiki M, Tomita Y, Igawa Y, Yanagisawa A, Uchiyama S, Watanabe K, Aida Y.
    Hinyokika Kiyo; 1987 Feb; 33(2):319-26. PubMed ID: 3591595
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of long-term administration with terodiline hydrochloride for the treatment of patients with neurogenic bladder].
    Ishido T, Miyazaki K.
    Hinyokika Kiyo; 1988 Apr; 34(4):754-8. PubMed ID: 3400554
    [Abstract] [Full Text] [Related]

  • 8. [Clinical study of terodiline hydrochloride on nervous pollakisuria].
    Park YC, Uchida A, Ohnishi N, Kiwamoto H, Esa A, Sugiyama T, Kaneko S, Kurita T.
    Hinyokika Kiyo; 1989 Mar; 35(3):537-40. PubMed ID: 2735258
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of long-term administration of terodiline hydrochloride for the treatment of patients with pollakisuria and incontinence].
    Tsujimoto Y, Fujisue H, Shima H, Ikoma F, Sakurai T, Sato Y, Tokizane M, Akiyama K, Kato S, Nakachi K.
    Hinyokika Kiyo; 1988 Apr; 34(4):724-32. PubMed ID: 3400552
    [Abstract] [Full Text] [Related]

  • 10. [Clinical effect of terodiline hydrochloride on pollakisuria and urinary incontinence].
    Sugiyama T, Kiwamoto H, Uchida A, Nagai N, Park YC, Kurita T, Ikegami M, Nakanishi A, Kawamura M, Umekawa T.
    Hinyokika Kiyo; 1990 Nov; 36(11):1371-7. PubMed ID: 2288317
    [Abstract] [Full Text] [Related]

  • 11. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.
    Peters D.
    Scand J Urol Nephrol Suppl; 1984 Nov; 87():21-33. PubMed ID: 6399953
    [Abstract] [Full Text] [Related]

  • 12. [Clinical effectiveness of KL 007 (oxybutynin hydrochloride) in urinary disorders].
    Takimoto Y, Kiyotaki S, Kawazoe K, Fuse T, Kitamura K, Yamamoto T, Satoh Y, Okada K, Kishimoto T.
    Hinyokika Kiyo; 1985 Dec; 31(12):2284-301. PubMed ID: 3832931
    [Abstract] [Full Text] [Related]

  • 13. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M, Kato K, Kondo A, Otani T, Takita T, Kobayashi M.
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [Abstract] [Full Text] [Related]

  • 14. Terodiline treatment of detrusor hyperreflexia in sclerosis multiplex.
    Jensen D.
    J Oslo City Hosp; 1989 Mar; 39(6-7):67-73. PubMed ID: 2674379
    [Abstract] [Full Text] [Related]

  • 15. The effect of terodiline on patients with detrusor instability.
    Macfarlane JR, Tolley DA.
    Scand J Urol Nephrol Suppl; 1984 Mar; 87():51-4. PubMed ID: 6399954
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder--a double-blind study].
    Koyanagi T, Togashi M, Maru A, Orikasa S, Soma F, Shimazaki J, Yasuda K, Aso Y, Honma Y, Miyake K.
    Hinyokika Kiyo; 1990 Oct; 36(10):1233-52. PubMed ID: 1979900
    [Abstract] [Full Text] [Related]

  • 17. [Effect of Robaveron tablet (KN-7) in the long-term therapy for urinary disturbances].
    Yamada K, Shiomi T, Momose H, Yamamoto M, Okamura K, Suemori T.
    Hinyokika Kiyo; 1985 May; 31(5):901-6. PubMed ID: 4050635
    [Abstract] [Full Text] [Related]

  • 18. A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.
    Petersen T, Jakobsen J.
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1331-6. PubMed ID: 3681312
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.
    Fischer-Rasmussen W.
    Scand J Urol Nephrol Suppl; 1984 Oct; 87():35-47. PubMed ID: 6443541
    [Abstract] [Full Text] [Related]

  • 20. [The use of dimethyl sulfoxide in the treatment of intractable urinary frequency].
    Okamura K, Mizunaga M, Arima S, Tokunaka S, Inada F, Takamura T, Yachiku S.
    Hinyokika Kiyo; 1985 Apr; 31(4):627-31. PubMed ID: 4036738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.